Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.20% | 157.98 | 0.7% | $1165.17m | |
| PFE | Pfizer Inc. | 0.28% | 34.49 | 0.9% | $1067.32m | |
| MRK | Merck & Co., Inc. | 2.10% | 74.67 | 0.7% | $877.51m | |
| BMY | Bristol-Myers Squibb Co. | 0.72% | 60.87 | 1.0% | $840.70m | |
| ABBV | AbbVie, Inc. | 0.25% | 106.97 | 1.9% | $718.22m | |
| LLY | Eli Lilly & Co. | 0.33% | 207.61 | 1.1% | $637.99m | |
| AZN | AstraZeneca Plc | 0.27% | 48.19 | 1.2% | $487.64m | |
| GSK | GlaxoSmithKline Plc | 0.63% | 35.13 | 0.2% | $274.14m | |
| NVS | Novartis AG | -0.13% | 83.90 | 0.2% | $166.11m | |
| SNY | Sanofi | 0.24% | 46.70 | 0.2% | $163.54m | |
| VTRS | Viatris, Inc. | -0.50% | 13.84 | 0.0% | $133.84m | |
| VERU | Veru, Inc. | 1.26% | 12.49 | 0.0% | $122.62m | |
| KALV | KalVista Pharmaceuticals, Inc. | -1.54% | 30.41 | 0.4% | $98.10m | |
| NVO | Novo Nordisk A/S | -0.70% | 69.12 | 0.1% | $90.72m | |
| RPRX | Royalty Pharma Plc | 5.95% | 45.07 | 0.2% | $84.42m |
Company Profile
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.